SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 IN A DOSE ESCALATING REGIMEN IN PATIENTS WITH METASTATIC RENAL-CELL ADENOCARCINOMA

被引：0
|
作者：
WHITEHEAD, RP
WARD, D
HEMINGWAY, L
HEMSTREET, GP
BRADLEY, E
KONRAD, M
机构：
[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT MED,OKLAHOMA CITY,OK 73190
[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT UROL,OKLAHOMA CITY,OK 73190
[3] CETUS CORP,EMERYVILLE,CA 94608
来源：
CANCER RESEARCH | 1990年 / 50卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6708 / 6715
页数：8
相关论文
共 50 条
  • [31] PEDIATRIC RENAL-CELL CARCINOMA - A COMPLETE RESPONSE TO RECOMBINANT INTERLEUKIN-2 IN A CHILD WITH METASTATIC DISEASE AT DIAGNOSIS
    MACARTHUR, CA
    ISAACS, H
    MILLER, JH
    OZKAYNAK, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 23 (04): : 365 - 371
  • [32] TREATMENT OF PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERFERON-ALPHA-2B AND CONTINUOUS-INFUSION OF RECOMBINANT INTERLEUKIN-2 - A PHASE-II STUDY
    MORANT, R
    RICHNER, J
    AAPRO, M
    PALMER, PA
    SENN, HJ
    ONKOLOGIE, 1994, 17 (03): : 254 - 260
  • [33] INTERLEUKIN-2 BY INHALATION - LOCAL THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    HULAND, E
    HULAND, H
    HEINZER, H
    JOURNAL OF UROLOGY, 1992, 147 (02): : 344 - 348
  • [34] HAS INTERLEUKIN-2 MODIFIED THE OUTCOME OF METASTATIC RENAL-CELL CANCER
    NEGRIER, S
    PHILIP, T
    ANNALES D UROLOGIE, 1993, 27 (02) : 87 - 89
  • [35] LOW-DOSE REGIMEN OF INTERLEUKIN-2 FOR METASTATIC RENAL-CARCINOMA
    SLEIJFER, DT
    JANSSEN, RAJ
    WILLEMSE, PHB
    MARTENS, A
    DELEIJ, L
    DEVRIES, EGE
    MULDER, NH
    LANCET, 1990, 335 (8704): : 1522 - 1523
  • [36] HAS INTERLEUKIN-2 MODIFIED THE OUTCOME OF METASTATIC RENAL-CELL CANCER
    NEGRIER, S
    PHILIP, T
    ANNALES DE CHIRURGIE, 1992, 46 (05): : 373 - 375
  • [37] COMBINATION RECOMBINANT INTERLEUKIN-2 RECOMBINANT INTERFERON-2, AND 5-FLUOROURACIL FOR TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    UENO, NT
    ZUKIWSKI, AA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (04): : 358 - 362
  • [38] TREATMENT OF ADVANCED RENAL-CELL CANCER WITH SEQUENTIAL INTRAVENOUS RECOMBINANT INTERLEUKIN-2 AND SUBCUTANEOUS ALPHA-INTERFERON
    BESANA, C
    BORRI, A
    BUCCI, E
    CITTERIO, G
    DILUCCA, G
    FORTIS, C
    MATTEUCCI, P
    TOGNELLA, S
    TRESOLDI, M
    BAIOCCHI, C
    LANDONIO, G
    GHISLANDI, E
    RUGARLI, C
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1292 - 1298
  • [39] METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING
    FARACE, F
    PALLARDY, M
    ANGEVIN, E
    HERCEND, T
    ESCUDIER, B
    TRIEBEL, F
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (06) : 814 - 821
  • [40] RENAL-CELL CARCINOMA WITH SUBCUTANEOUS INJECTIONS OF INTERLEUKIN-2 AND INTERFERON-ALPHA
    HOFMOCKEL, G
    THEISS, M
    BUSSEN, D
    WIRTH, MP
    FROHMULLER, HGW
    UROLOGE-AUSGABE A, 1994, 33 (05): : 434 - 439
12345